US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Latest News about FDA Priority Review

Recent news which mentions FDA Priority Review

Agios' Rare Anemia Drug Application Under FDA Priority Review
Tickers AGIO
Tags Health Care Briefs General
From Benzinga
Liminal BioSciences Stock Is Trading Higher On Sale Of Priority Review Voucher For $105M
Tickers LMNL
Tags Asset Sales Briefs Health Care
From Benzinga
Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority Review
Tickers DARE
Tags FDA Long Ideas News
From Benzinga
Roche's Tecentriq As Adjuvant Treatment Under Priority Review With FDA For Early Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Market News News Briefs
From Benzinga